Trillium Health Partners

Gesund.ai Named to the 2024 CB Insights AI 100 List

Retrieved on: 
Tuesday, April 2, 2024
Electricity, Government, Netflix, Health, Partnership, Lightning, Patient, CB Insights, Research, AI, NIST, Commerce, Accelerator, Ecosystem, Safety, Trillium Health Partners, World Bank, Medical device

NEW YORK, April 2, 2024 /PRNewswire/ -- CB Insights today named Gesund.ai to its eighth-annual AI 100, showcasing the 100 most promising private AI companies of 2024."AI is taking off at lightning speed, and it's not just big tech companies at the forefront of it," said Deepashri Varadharajan, director of AI research at CB Insights. "Our AI 100 winners – many of them early stage startups, some with very small teams – are pushing the boundaries of AI in everything from game development and battery design to agentic AI systems.""Regulatory tailwinds coming from many directions are putting AI validation under an international spotlight, signaling an end to the 'Wild West' era of AI in healthcare. We are thrilled to have received this level of recognition as a young organization developing the mission-critical infrastructure, equipped with the necessary tools and guardrails to protect and serve all AI stakeholders in the ecosystem, from patients and health systems to government agencies and technology developers," asserted Dr. Enes Hosgor, CEO and founder of Gesund.ai.The 100 winners were chosen based on several factors, including CB Insights' data on deal activity, industry partnerships, team strength, investor strength, patent activity, and proprietary Mosaic Scores. We also analyzed CB Insights' exclusive interviews with software buyers and dug into Analyst Briefings submitted directly to us by startups.Gesund.ai is spearheading a groundbreaking era in medical AI, akin to the transformative impact of electricity. Our core objective is to establish a robust infrastructure that ensures the safety, effectiveness, and accessibility of AI in healthcare.Central to our approach is a rigorous AI validation process, facilitating reliability and regulatory compliance. With our healthcare-tailored and AI-native platform and strategic partnerships, including data custodians and expert physician annotators, we ensure precision and adherence to industry and regulatory standards.This year, Gesund.ai has achieved remarkable milestones, including selection for the CancerX Accelerator, a part of the White House moonshot initiative; and joining prestigious organizations like the U.S. AI Safety Institute Consortium under NIST and the U.S. Department of Commerce; and VALID AI, a collaborative comprising prominent health systems driving the adoption of responsible AI in healthcare. Our international expansion, crucial to our AI assurance network, is exemplified by our partnership with Trillium Health Partners based in Canada, further cementing our commitment to global impact.As leaders in responsible AI, Gesund.ai remains steadfast in our mission to revolutionize healthcare through cutting-edge technology and unwavering excellence.Quick facts on the 2024 AI 100:

Key Points: 
  • NEW YORK, April 2, 2024 /PRNewswire/ -- CB Insights today named Gesund.ai to its eighth-annual AI 100 , showcasing the 100 most promising private AI companies of 2024.
  • "AI is taking off at lightning speed, and it's not just big tech companies at the forefront of it," said Deepashri Varadharajan, director of AI research at CB Insights.
  • "Our AI 100 winners – many of them early stage startups, some with very small teams – are pushing the boundaries of AI in everything from game development and battery design to agentic AI systems."
  • "Regulatory tailwinds coming from many directions are putting AI validation under an international spotlight, signaling an end to the 'Wild West' era of AI in healthcare.

Gesund is Proud to Announce International Expansion of its AI Assurance Platform Partner Network With Trillium Health Partners

Retrieved on: 
Friday, March 8, 2024
Bias, IBH, Ethics, AI, Research, FDA, News, Work, Trillium Health Partners, THP, White, Moonshot, Safety, Certification, Accelerator, Privacy, MLOps, VIVE, Partnership, Medical device

BOSTON and BERLIN, March 8, 2024 /PRNewswire/ -- Gesund, the company ensuring that medical artificial intelligence (AI) is safe, equitable, and effective for all, today announces its innovative partnership with the Institute for Better Health (IBH) at Trillium Health Partners (THP), a leading health system in Toronto. For the first time AI developers will be able to test their AI models on IBH's real-world data in situ with Gesund.ai's pioneering technology to elicit unique insights on their model's performance and areas for improvement (bias, blindspots, etc.). Sign up to join the waitlist. You will be notified if your application is approved.

Key Points: 
  • Gesund's AI Assurance Platform and experts are integrating THP's high-quality data to provide a unique opportunity for rapid pressure-testing of AI models.
  • Gesund.ai has shared this perspective since its inception and is enabling the world's first AI Assurance Network with its pioneering MLOps platform, on a mission to help transform research-grade AI to clinical-grade AI 10x more efficiently.
  • Gesund uses its proprietary, groundbreaking platform to deliver industry-leading independent third-party validation of AI for pharma and medical device companies, as well as other AI developers.
  • In February, it joined VALID AI, a coalition of 60 U.S. health systems focused on the practice of trustworth AI.

Improving the working lives of nurses across Canada

Retrieved on: 
Monday, March 4, 2024
Well, Anxiety, Mental health, Medical Council, Credit Valley Hospital, Workplace, International, Express Entry, School, Education, Surgeon, RNS, Trillium Health Partners, PER, Royal college, Health, RCPSC, Communication, Government, Practitioner, Clinical governance, Organization, Patient, Burnout, Physician, Depression, Nursing

To help support and retain members of the nursing workforce, today, the Honourable Mark Holland, Canada's Minister of Health joined Dr. Leigh Chapman, Canada's Chief Nursing Officer at Trillium Health Partners, Credit Valley Hospital, to announce the release of the Nursing Retention Toolkit: Improving the Working Lives of Nurses in Canada to help improve the working lives of nurses.

Key Points: 
  • To help support and retain members of the nursing workforce, today, the Honourable Mark Holland, Canada's Minister of Health joined Dr. Leigh Chapman, Canada's Chief Nursing Officer at Trillium Health Partners, Credit Valley Hospital, to announce the release of the Nursing Retention Toolkit: Improving the Working Lives of Nurses in Canada to help improve the working lives of nurses.
  • The toolkit will be shared widely throughout Canada's health care system- including with nurses, nursing employers, and health authorities across the country.
  • As a resource created by nurses and for nurses, the toolkit is the result of a collaborative effort with the nursing community which shares the federal government's commitment to improve nursing retention in Canada.
  • Category-based selection allows Canada to issue invitations to apply to prospective permanent residents with specific work experience, including in health care.

Homecare Hub & Penguin Living open Hamilton Residential Assisted Living Homes - Plan for up 200 beds over the next year in Response to Long-Term Care Crisis

Retrieved on: 
Monday, January 8, 2024
Penguin, IBM, Cleveland Clinic, Family, Partnership, Toronto-Dominion Bank, Friends, Internal medicine, Nursing, Long-term care, Disability, Pressure, Housing, University, Ageing, Assisted living, Trillium Health Partners, Bed

HAMILTON, ON, Jan. 8, 2024 /PRNewswire/ - Homecare Hub and Penguin Living proudly announce the opening of their newest assisted living residences in Hamilton, Ontario.

Key Points: 
  • HAMILTON, ON, Jan. 8, 2024 /PRNewswire/ - Homecare Hub and Penguin Living proudly announce the opening of their newest assisted living residences in Hamilton, Ontario.
  • The opening of their 3 houses in Warren Park last month marked the first set of many small-scale residential assisted living homes that will be created in Hamilton.
  • Their first 30 beds are available now, with an on-demand system that allows for the system to scale up.
  • For more information about the new Assisted Living communities being built, or Homecare Hub and its innovative senior housing and home care solutions, please visit www.homecarehub.ca/shared-living or call Homecare Hub at 1-888-227-3080.

Sun Life announces Manjit Singh as new President of Sun Life Asia

Retrieved on: 
Monday, December 11, 2023
NYSE, Harvard Business School, Advanced Management Program, University, SLF, CFA, Sun Life Financial, Sun, Health, Financial services, Manjit Singh (armament scientist), Business administration, Growth, Business, Trillium Health Partners, TSX, Management, Renewable energy, Hong Kong, Manjit

TORONTO, Dec. 11, 2023 /PRNewswire/ - Kevin Strain, President and Chief Executive Officer of Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) today announced Manjit Singh will become the new President of Sun Life Asia effective March 18, 2024.

Key Points: 
  • TORONTO, Dec. 11, 2023 /PRNewswire/ - Kevin Strain, President and Chief Executive Officer of Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) today announced Manjit Singh will become the new President of Sun Life Asia effective March 18, 2024.
  • Mr. Singh succeeds Ingrid Johnson, who has taken on the newly created role of Vice-Chair, Strategic Partnerships for Sun Life globally.
  • "I'm incredibly honoured and excited to take on this new role and opportunity at Sun Life Asia," said Mr. Singh.
  • An active and passionate community leader, Manjit is currently a Board Member of Trillium Health Partners and formerly the President of ASCEND Canada.

Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services

Retrieved on: 
Thursday, November 23, 2023
Diamond, RSNA, Research, International, Google Images, Medicine, KLAS, Workflow, VNA, Diagnosis, Hospital, AI, Trillium Health Partners, Health, THP, Medical device, Sectra AB, MISSISSAUGA

LINKÖPING, Sweden and MISSISSAUGA, ON, Nov. 23, 2023 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement via Sectra Amplifier Services.

Key Points: 
  • LINKÖPING, Sweden and MISSISSAUGA, ON, Nov. 23, 2023 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement via Sectra Amplifier Services.
  • This will enable THP to introduce AI-powered workflows in its diagnostic imaging department, which will help identify serious health conditions sooner, allowing for earlier intervention and better health outcomes.
  • The Sectra Amplifier Service is a fully managed, cloud-hosted AI service and offers clients a wide range of validated third-party AI applications.
  • Using the Sectra Amplifier Service to deploy this tool has significantly simplified the process in integrating AI into our workflow."

Hexiris Pharma Welcomes World-Renowned Ophthalmologist Dr. Ike Ahmed to its Scientific Committee

Retrieved on: 
Monday, October 30, 2023
Knowledge, American Academy of Ophthalmology, FDA, Research, AGS, American Glaucoma Society, Vision, Slit lamp, ASCRS, Refractive surgery, ISGS, Glaucoma, MIGS, Pressure, MD, University of Utah, AAO, Glaucoma surgery, Alan, University, COS, Cataract, Trillium Health Partners, University of Toronto, Eye, Visual Science, CGS, American Society of Cataract and Refractive Surgery, International Society, ARVO, Scientific Committee on Emerging and Newly Identified Health Risks, Patient, Diagnosis, Medical device, Ophthalmology

DIEPPE, New Brunswick, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hexiris Pharma Inc. (“Hexiris Pharma” or the “Company”), a pharmaceutical firm dedicated to advancing and simplifying Minimally Invasive Glaucoma Surgery (MIGS), is pleased to announce that world-renowned ophthalmologist Dr. Ike Ahmed will join Hexiris Pharma’s Scientific Committee.

Key Points: 
  • DIEPPE, New Brunswick, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hexiris Pharma Inc. (“Hexiris Pharma” or the “Company”), a pharmaceutical firm dedicated to advancing and simplifying Minimally Invasive Glaucoma Surgery (MIGS), is pleased to announce that world-renowned ophthalmologist Dr. Ike Ahmed will join Hexiris Pharma’s Scientific Committee.
  • “We are truly honoured that Dr. Ahmed has agreed to join Hexiris Pharma’s Scientific Committee,” said Dr. Nir Shoham-Hazon, Co-Founder and Co-CEO of Hexiris Pharma.
  • I’m pleased to be joining the Scientific Committee at Hexiris Pharma and join in the important work of improving the lives of patients and bringing new solutions and opportunities to ophthalmologists,” said Dr. Ahmed.
  • He has given over 750 scientific presentations thus far in his career, including 31 visiting professor’s lectures around the world.

PMPRB announces next steps in Guidelines consultation process

Retrieved on: 
Wednesday, October 25, 2023
Trillium Health Partners, Guideline, Alignment, Private, South Korean Patent Act, Patent Act, Patent, PMPRB, Round Table, Music, Pharmaceutical industry

At the Roundtable, stakeholders will be invited to share their views on the development of new Guidelines.

Key Points: 
  • At the Roundtable, stakeholders will be invited to share their views on the development of new Guidelines.
  • Interested stakeholders are encouraged to follow the PMPRB on X (formerly Twitter), to stay informed of new developments and announcements.
  • The Guidelines explain the procedures used by staff at the PMPRB when monitoring the prices of patented medicines.
  • On September 27, 2023, the PMPRB published its decision on Amended Interim Guidance.

Revolutionary Senior Care Platform Homecare Hub Sets Sights on Expansion, Secures Strategic Seed Funding from Inception Health, Ballad Ventures, CABHI, Blue Lion Global, AARP

Retrieved on: 
Tuesday, September 26, 2023
Cloud, Medicine, Housing, Investment, Long-term care, Dignity, Toronto-Dominion Bank, Hospital for Sick Children, Goldman Sachs, Hospital, Patient, Cleveland, Cleveland Clinic, University, Internal medicine, TD, Ageing, Froedtert Health, Organization, Dementia, Becker's Hospital Review, University of Waterloo, VC, Senior, AARP, Medical college, Uber, Baycrest Health Sciences, TD Bank Ballpark, Tufts Medical Center, IBM, Partnership, Ballad Health, Airbnb, Quality of life, Froedtert Hospital, Trillium Health Partners, Nursing

The oversubscribed $2.5 Million USD round exceeded initial targets, and additional milestone-based funding was also secured.

Key Points: 
  • The oversubscribed $2.5 Million USD round exceeded initial targets, and additional milestone-based funding was also secured.
  • "Homecare Hub is leading the way in closing the gaps for complex hospital discharges.
  • "With Homecare Hub, we're investing in the future of more personalized, high-quality, and affordable care options in both post-acute and long-term care.
  • The Blue Lion Global Fund participated and placed operating partner Matt Atkin to play a hands-on role on at Homecare Hub.

Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians

Retrieved on: 
Tuesday, July 4, 2023
Health, Medical Devices, Diabetes, Technology, Health Technology, Wearables, Mobile Technology, Hardware, CGM, Unity Health Toronto, Compatibility, Quality of life, Credit Valley Hospital, Multimedia, Trillium Health Partners, Hypoglycemia, G6, Patient, DXCM, Health Canada, Family, Caregiver, Disease, Medical device, Dexcom

Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that Health Canada has approved the next-generation Dexcom G7 Continuous Glucose Monitoring System for people with all types of diabetes, ages two years and older.

Key Points: 
  • Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that Health Canada has approved the next-generation Dexcom G7 Continuous Glucose Monitoring System for people with all types of diabetes, ages two years and older.
  • View the full release here: https://www.businesswire.com/news/home/20230704730937/en/
    Dexcom G7 receives Health Canada approval.
  • Dexcom G7 builds on the innovation that our previous CGM systems have brought to the lives of Canadians.
  • Dexcom Canada is working diligently to bring Dexcom G7 to Canadians living with diabetes by the end of 2023.